Stock Events

Stock Events

Bellevue Group 

CHF8
17
+CHF0.18+2.3% Thursday 16:06

Statistics

Day High
8.06
Day Low
8
52W High
38
52W Low
8
Volume
2,446
Avg. Volume
1,032
Mkt Cap
0
P/E Ratio
0.03
Dividend Yield
1.88%
Dividend
0.15

Upcoming

26
MAR 27
Dividend Ex
Estimated
 
30
MAR 27
Dividend Payment
Estimated
 
27
MAR 28
Dividend Ex
Estimated
 
31
MAR 28
Dividend Payment
Estimated
 

Dividends

1.88%Dividend Yield
Mar 26
CHF0.15
Mar 25
CHF0.7
Mar 24
CHF1.15
Mar 23
CHF2
Mar 22
CHF2.7
10Y Growth
-17.28%
5Y Growth
-36.9%
3Y Growth
-57.83%
1Y Growth
-78.57%

Earnings

24FebExpected
Q4 2022
Q2 2023
Q4 2023
Q2 2024
Q4 2024
Q2 2025
Q4 2025
999
333
-333
-999
Expected EPS
N/A
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 0QLZ.LSE. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Novartis
NVS
Mkt Cap237.61B
Novartis is a global healthcare company that competes with Bellevue in the pharmaceutical and healthcare investment sectors.
Roche
RHHBY
Mkt Cap258.9B
Roche Holding AG is a major player in the pharmaceuticals and diagnostics market, directly competing with Bellevue's investments in healthcare.
Pfizer
PFE
Mkt Cap140.15B
Pfizer is a leading pharmaceutical company, competing with Bellevue in the healthcare and pharmaceutical investment space.
Merck
MRK
Mkt Cap214.76B
Merck & Co., Inc. is a global healthcare company that competes with Bellevue through its pharmaceutical products and healthcare solutions.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson is a comprehensive healthcare firm that competes across various segments, including pharmaceuticals, medical devices, and consumer health products.
Abbvie
ABBV
Mkt Cap385.18B
AbbVie is a biopharmaceutical company that competes with Bellevue in the healthcare investment sector, particularly in pharmaceuticals.
AMGEN
AMGN
Mkt Cap160.66B
Amgen is a biotechnology firm competing with Bellevue in the biopharmaceutical investment space.
GSK
GSK
Mkt Cap94.51B
GlaxoSmithKline is a global healthcare company, competing with Bellevue in pharmaceuticals and healthcare products.
Bristol-Myers Squibb
BMY
Mkt Cap93.79B
Bristol Myers Squibb is a global biopharmaceutical company, competing with Bellevue in the development and commercialization of pharmaceuticals.
Sanofi
SNY
Mkt Cap124.45B
Sanofi is a global biopharmaceutical company competing with Bellevue in the healthcare and pharmaceutical sectors.

About

Bellevue Group AG provides asset management services in Switzerland, the United Kingdom, Germany, and internationally. The company offers healthcare investment solutions, including biotech, medtech, thematic, and healthcare global and regional. It also provides small and mid-sized entrepreneur investment solutions, such as listed small and mid caps, and private equity strategies; and multi asset, bonds, and alternatives. In addition, the company offers investment funds, as well as investment solutions for institutional, intermediary and private clients. The company was founded in 1993 and is headquartered in Zurich, Switzerland.
Show more...
CEO
Mr. Veit D. de Maddalena
Employees
84
Country
CH
ISIN
CH0028422100

Listings

LSE
GB
0QLZ.LSE
F
DE
SJZN.F
SW
CH
BBN.SW

0 Comments

Share your thoughts

FAQ

What is Bellevue Group stock price today?▼
The current price of 0QLZ.LSE is CHF8 CHF — it has increased by +2.3% in the past 24 hours. Watch Bellevue Group stock price performance more closely on the chart.
What is Bellevue Group stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Bellevue Group stocks are traded under the ticker 0QLZ.LSE.
Is Bellevue Group stock price growing?▼
0QLZ.LSE stock has risen by +2.3% compared to the previous week, the month change is a -6.1% fall, over the last year Bellevue Group has showed a -1.11% decrease.
Does Bellevue Group pay dividends?▼
Yes, 0QLZ.LSE dividends are paid annual. The last dividend per share was 0.15 CHF. As of today, Dividend Yield (FWD)% is 1.88%.
How many employees does Bellevue Group have?▼
As of April 04, 2026, the company has 84 employees.
In which sector is Bellevue Group located?▼
Bellevue Group operates in the Industrials sector.
When did Bellevue Group complete a stock split?▼
Bellevue Group has not had any recent stock splits.
Where is Bellevue Group headquartered?▼
Bellevue Group is headquartered in Zurich, CH.